1. Home
  2. INTS vs NDLS Comparison

INTS vs NDLS Comparison

Compare INTS & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • NDLS
  • Stock Information
  • Founded
  • INTS 2012
  • NDLS 1995
  • Country
  • INTS United States
  • NDLS United States
  • Employees
  • INTS N/A
  • NDLS N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • NDLS Restaurants
  • Sector
  • INTS Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • INTS Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • INTS 33.4M
  • NDLS 34.3M
  • IPO Year
  • INTS 2023
  • NDLS 2013
  • Fundamental
  • Price
  • INTS $2.20
  • NDLS $1.50
  • Analyst Decision
  • INTS Strong Buy
  • NDLS Strong Buy
  • Analyst Count
  • INTS 3
  • NDLS 2
  • Target Price
  • INTS $8.50
  • NDLS $3.00
  • AVG Volume (30 Days)
  • INTS 40.1K
  • NDLS 355.5K
  • Earning Date
  • INTS 03-13-2025
  • NDLS 03-06-2025
  • Dividend Yield
  • INTS N/A
  • NDLS N/A
  • EPS Growth
  • INTS N/A
  • NDLS N/A
  • EPS
  • INTS N/A
  • NDLS N/A
  • Revenue
  • INTS N/A
  • NDLS $495,817,000.00
  • Revenue This Year
  • INTS N/A
  • NDLS $0.24
  • Revenue Next Year
  • INTS N/A
  • NDLS $0.19
  • P/E Ratio
  • INTS N/A
  • NDLS N/A
  • Revenue Growth
  • INTS N/A
  • NDLS N/A
  • 52 Week Low
  • INTS $1.50
  • NDLS $0.55
  • 52 Week High
  • INTS $5.94
  • NDLS $2.68
  • Technical
  • Relative Strength Index (RSI)
  • INTS 54.20
  • NDLS 68.95
  • Support Level
  • INTS $2.00
  • NDLS $1.30
  • Resistance Level
  • INTS $2.37
  • NDLS $1.73
  • Average True Range (ATR)
  • INTS 0.31
  • NDLS 0.17
  • MACD
  • INTS -0.00
  • NDLS 0.02
  • Stochastic Oscillator
  • INTS 48.24
  • NDLS 73.26

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: